Scarica l'app Stockscreener
21.19
0.05%
-0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Artivion Inc Borsa (AORT) Ultime notizie
Delray Medical Center is First Hospital in Palm Beach County to Perform Procedure Using AMDS™ Hybrid Prothesis Developed by Artivion Inc. - Florida Hospital News and Healthcare Report
Artivion Inc (AORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Artivion Inc (AORT) Institutional Confidence - TradingKey
Artivion Inc (AORT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Artivion Inc (AORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Artivion Inc (AORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artivion Inc (AORT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Artivion Inc (AORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Artivion Inc (AORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Artivion’s Andrew Green sells $910,738 in company stock - Investing.com UK
Artivion’s Andrew Green sells $910,738 in company stock By Investing.com - Investing.com India
Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing - marketscreener.com
Artivion (AORT) SVP exercises options and sells 44,001 shares under 10b5-1 plan - Stock Titan
Precision Trading with Artivion Inc Com (AORT) Risk Zones - Stock Traders Daily
AORT Q1 2026 Earnings: EPS Misses Estimates as Profitability Pressures EmergeAnalyst Coverage Count - The League of Women Voters of Texas
What Artivion (AORT)'s Strong Q1 Growth But Lowered Guidance Means For Shareholders - Yahoo Finance
Artivion secures FDA approval for NEXUS aortic arch system - MSN
[144] ARTIVION, INC. SEC Filing - Stock Titan
Will Stronger Revenue but Softer Outlook Change Artivion's (AORT) Growth-Quality Narrative? - simplywall.st
Artivion to present at 2026 Truist Securities MedTech Conference with live webcast on June 16 - Pluang
Artivion to Participate in the 2026 Truist Securities MedTech Conference - marketscreener.com
Cardiac surgery company Artivion joins 2026 Truist MedTech conference in Boston - Stock Titan
Analysts Offer Insights on Healthcare Companies: Artivion (AORT), Incyte (INCY) and ClearPoint Neuro (CLPT) - The Globe and Mail
Artivion (AORT) Stock Forum and Discussion - Moomoo
Artivion (AORT) Q1 2026 Earnings: Revenue Growth of 17.5% Meets Expectations Amid Mixed Industry Results - IndexBox
Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Artivion (AORT) SVP discloses common stock, RSU and option holdings - Stock Titan
Estate move: Artivion (AORT) director moves 6,325 shares into trust - Stock Titan
Artivion, Inc. has exercised option to acquire Endospan Ltd. for approximately $380 million. - marketscreener.com
Artivion Inc. (AORT) Slips 0.76% as Stock Tests Key Support Near $19.85Hull Moving Average - thelegaladvocate.com
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48 - Moomoo
Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Stifel reiterates Artivion stock rating on surgeon survey results - Investing.com
Stifel reiterates Artivion stock rating on surgeon survey results By Investing.com - Investing.com South Africa
AORT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Artivion (AORT) Earnings Date and Reports 2026 $AORT - MarketBeat
Artivion Inc. (AORT) Holds Near Support as Mild Pullback Tests Recent RangeIchimoku TK Cross - thelegaladvocate.com
Artivion Inc. (AORT) Faces Selling Pressure as Shares Dip Below Key Moving AveragesTechnical Analysis - thelegaladvocate.com
Artivion Q1 earnings call highlights - MSN
AORT News | ARTIVION INC (NYSE:AORT) - ChartMill
Artivion (AORT) Q1 earnings and revenues surpass estimates - MSN
Artivion (AORT) director corrects details of restricted stock award - Stock Titan
Director at Artivion (NYSE: AORT) awarded 7,576 restricted shares - Stock Titan
Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System - MedTech Intelligence
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Yahoo Finance
Artivion (AORT) director receives 7,576-share equity RSA grant - Stock Titan
Artivion (AORT) director receives 7,850-share stock award, now holds 56,938 - Stock Titan
Artivion Earnings Call Balances Growth With Caution - TipRanks
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):